Nature Neuroscience, Published online: 21 March 2024; doi:10.1038/s41593-024-01609-3Hematopoietic cell transplantation (HCT) may be a promising therapy for treatment-refractory multiple sclerosis (MS). Mader et al. Describe beneficial effects of autologous HCT in a mouse model of MS and identify a myeloid transcriptional signature associated with neuroprotection.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Marius Marc-Daniel Mader | March 21, 2024
Nature Neuroscience